Type 1 DiabetesExpert Weighs In: FDA Alert Highlights Hidden Risks in Diabetes AppsFebruary 11, 2025Type 2 DiabetesCan New Weight Loss Drugs Cause Blindness? New Study Adds to DebateFebruary 11, 2025Type 1 DiabetesSmartphone Settings May Block Critical Diabetes Device Alerts, FDA WarnsFebruary 5, 2025Type 1 DiabetesYo-Yo Dieting Linked to Chronic Kidney Disease in Type 1 DiabetesFebruary 4, 2025Type 2 DiabetesAmazon Pharmacy’s RxPass Saves Patients Money, Improves Medication AdherenceFebruary 3, 2025Type 2 Diabetes5 Fast Facts on Heart Disease in the United States for American Heart Month 2025February 1, 2025Type 2 Diabetes5 Things to Know When Starting a GLP-1 Receptor Agonist, with Diana Isaacs, PharmDJanuary 24, 2025Thyroid DisordersDo GLP-1 Medications Increase Thyroid Cancer Risk? A New Study Weighs InJanuary 23, 2025Type 2 DiabetesCan Sparkling Water Spark Weight Loss?January 21, 2025Type 2 DiabetesGLP-1 RAs Show Broad Health Benefits Alongside Some RisksJanuary 21, 2025Type 2 DiabetesDiabetes, Obesity Drugs at Center of Latest CMS Medicare Part D Negotiation ListJanuary 20, 2025Type 2 DiabetesHow FDA’s Proposed Nutrition Labeling Could Help Consumers, with Jennifer Bianchini, MS, RDNJanuary 20, 2025Cushing SyndromeMifepristone Trial Shows Promising Results in Cushing Syndrome January 20, 2025Type 2 DiabetesMaking Sense of the CMS Drug Price Negotiation: What's Included and WhyJanuary 17, 2025Type 2 DiabetesFDA Proposes Front-of-Package Nutrition Label to Combat Chronic DiseaseJanuary 15, 2025Cushing SyndromePromising Six-Year Data Support Relacorilant as a New Cushing Syndrome TherapyJanuary 15, 2025Thyroid DisordersThyroid Dysfunction Increases Frailty Risk in Older AdultsJanuary 13, 2025Type 2 DiabetesUnlocking Diabetes Remission with Bariatric InterventionsJanuary 7, 2025Type 2 DiabetesSugar-Sweetened Beverages Significantly Linked to Type 2 Diabetes, Heart DiseaseJanuary 6, 2025Type 2 DiabetesOptimizing Your Diet While Taking OzempicJanuary 3, 2025
Type 1 DiabetesSmartphone Settings May Block Critical Diabetes Device Alerts, FDA WarnsFebruary 5, 2025
Type 2 DiabetesAmazon Pharmacy’s RxPass Saves Patients Money, Improves Medication AdherenceFebruary 3, 2025
Type 2 Diabetes5 Fast Facts on Heart Disease in the United States for American Heart Month 2025February 1, 2025
Type 2 Diabetes5 Things to Know When Starting a GLP-1 Receptor Agonist, with Diana Isaacs, PharmDJanuary 24, 2025
Thyroid DisordersDo GLP-1 Medications Increase Thyroid Cancer Risk? A New Study Weighs InJanuary 23, 2025
Type 2 DiabetesDiabetes, Obesity Drugs at Center of Latest CMS Medicare Part D Negotiation ListJanuary 20, 2025
Type 2 DiabetesHow FDA’s Proposed Nutrition Labeling Could Help Consumers, with Jennifer Bianchini, MS, RDNJanuary 20, 2025
Type 2 DiabetesMaking Sense of the CMS Drug Price Negotiation: What's Included and WhyJanuary 17, 2025
Type 2 DiabetesFDA Proposes Front-of-Package Nutrition Label to Combat Chronic DiseaseJanuary 15, 2025
Cushing SyndromePromising Six-Year Data Support Relacorilant as a New Cushing Syndrome TherapyJanuary 15, 2025
Type 2 DiabetesSugar-Sweetened Beverages Significantly Linked to Type 2 Diabetes, Heart DiseaseJanuary 6, 2025
